A series of activated and suppressed pathways were identified including “epithelial mesenchymal transition”, “IL6/JAK/STAT3 signaling”, “complement”, “E2F targets”, and “DNA repair”, which are highly involved in the initiation and progression of ccRCC. This evidence concerns the gene STAT3 and nonpapillary renal cell carcinoma.